Biotech Wins Dismissal Of Investor Fraud Claims

A Boston federal judge on Friday dismissed a proposed investor class action against biotech Aldeyra Therapeutics Inc., ruling that the lawsuit's facts tend to support innocent explanations for executives' statements about...

Already a subscriber? Click here to view full article